🇺🇸 FDA
Patent

US 7196119

Development of new selective estrogen receptor modulators

granted A61PA61P15/00A61P15/12

Quick answer

US patent 7196119 (Development of new selective estrogen receptor modulators) held by The Regents of the University of California expires Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61P, A61P15/00, A61P15/12, A61P19/00, A61P19/02